{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:03:05Z","timestamp":1792202585786,"version":"4.4.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014215","name":"Huxiang Youth Talent Support Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014215","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Hubei Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.xcrm.2025.102371","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T20:14:05Z","timestamp":1758831245000},"page":"102371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Vorapaxar enhanced mitochondria-associated ferroptosis primes cancer immunotherapy via targeting FOXO1\/HMOX1 axis"],"prefix":"10.1016","volume":"6","author":[{"given":"Qian","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songtao","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Dian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiao","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhili","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwei","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangtong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102371_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41568-024-00760-0","article-title":"Stemness in solid malignancies: coping with immune attack","volume":"25","author":"Agudo","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.102371_bib2","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.xcrm.2025.102371_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2024.101220","article-title":"Thrombotic events associated with immune checkpoint inhibitors and novel antithrombotic strategies to mitigate bleeding risk","volume":"67","author":"Chen","year":"2024","journal-title":"Blood Rev."},{"key":"10.1016\/j.xcrm.2025.102371_bib4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","article-title":"The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions","volume":"42","author":"Lei","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102371_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108487","article-title":"HCAR1\/MCT1 Regulates Tumor Ferroptosis through the Lactate-Mediated AMPK-SCD1 Activity and Its Therapeutic Implications","volume":"33","author":"Zhao","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2025.102371_bib6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102371_bib7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","article-title":"CD8(+) T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4","volume":"40","author":"Liao","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102371_bib8","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.ccell.2024.10.010","article-title":"Itaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistance","volume":"42","author":"Lin","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102371_bib9","article-title":"Disruption of MerTK increases the efficacy of checkpoint inhibitor by enhancing ferroptosis and immune response in hepatocellular carcinoma","volume":"5","author":"Wang","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2025.102371_bib10","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1160\/TH14-11-0943","article-title":"Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes","volume":"114","author":"Schrottmaier","year":"2015","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.xcrm.2025.102371_bib11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41568-023-00639-6","article-title":"The dynamic role of platelets in cancer progression and their therapeutic implications","volume":"24","author":"Li","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.102371_bib12","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1182\/blood.2019003977","article-title":"Aspirin and antiplatelet treatments in cancer","volume":"137","author":"Tao","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.102371_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009805","article-title":"Propafenone facilitates mitochondrial-associated ferroptosis and synergizes with immunotherapy in melanoma","volume":"12","author":"Zhou","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2025.102371_bib14","first-page":"61","article-title":"BET inhibitors potentiate melanoma ferroptosis and immunotherapy through AKR1C2 inhibition","volume":"10","author":"Meng","year":"2023","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.xcrm.2025.102371_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102653","article-title":"Inhibiting SCD expression by IGF1R during lorlatinib therapy sensitizes melanoma to ferroptosis","volume":"61","author":"Zeng","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.xcrm.2025.102371_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2025.102371_bib17","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1073\/pnas.1821022116","article-title":"Ferroptosis as a target for protection against cardiomyopathy","volume":"116","author":"Fang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102371_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156139","article-title":"Shikonin induces ferroptosis in osteosarcomas through the mitochondrial ROS-regulated HIF-1alpha\/HO-1 axis","volume":"135","author":"Lu","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.xcrm.2025.102371_bib19","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1172\/JCI99032","article-title":"Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma","volume":"128","author":"Hassannia","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2025.102371_bib20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13024-021-00437-4","article-title":"High dose expression of heme oxigenase-1 induces retinal degeneration through ER stress-related DDIT3","volume":"16","author":"Li","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.xcrm.2025.102371_bib21","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/nm.2049","article-title":"Foxo1 integrates insulin signaling with mitochondrial function in the liver","volume":"15","author":"Cheng","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102371_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jhep.2011.05.023","article-title":"HO-1-STAT3 axis in mouse liver ischemia\/reperfusion injury: regulation of TLR4 innate responses through PI3K\/PTEN signaling","volume":"56","author":"Ke","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.xcrm.2025.102371_bib23","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1152\/physrev.00003.2016","article-title":"Heme Oxygenases in Cardiovascular Health and Disease","volume":"96","author":"Ayer","year":"2016","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.xcrm.2025.102371_bib24","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41419-023-06177-1","article-title":"FOXO family isoforms","volume":"14","author":"Santos","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2025.102371_bib25","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1021\/acsnano.1c09480","article-title":"Cell-Specific Metabolic Reprogramming of Tumors for Bioactivatable Ferroptosis Therapy","volume":"16","author":"Li","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.xcrm.2025.102371_bib26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature24297","article-title":"Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition","volume":"551","author":"Hangauer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102371_bib27","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.102371_bib28","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.chembiol.2019.01.008","article-title":"Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model","volume":"26","author":"Zhang","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.xcrm.2025.102371_bib29","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ng.356","article-title":"Braf(V600E) cooperates with Pten loss to induce metastatic melanoma","volume":"41","author":"Dankort","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2025.102371_bib30","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1038\/s41467-024-46422-5","article-title":"Mi-2beta promotes immune evasion in melanoma by activating EZH2 methylation","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102371_bib31","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1021\/acsnano.3c12499","article-title":"Photoactivatable Aptamer-CRISPR Nanodevice Enables Precise Profiling of Interferon-Gamma Release in Humanized Mice","volume":"18","author":"Liu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.xcrm.2025.102371_bib32","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41392-022-01067-y","article-title":"Multi-omics characterization and therapeutic liability of ferroptosis in melanoma","volume":"7","author":"He","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2025.102371_bib33","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ccell.2023.03.010","article-title":"Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma","volume":"41","author":"Campbell","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102371_bib34","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s40265-014-0252-2","article-title":"Vorapaxar: first global approval","volume":"74","author":"Poole","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.xcrm.2025.102371_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.14533","article-title":"Recombinant hirudin suppresses angiogenesis of diffuse large B-cell lymphoma through regulation of the PAR-1-VEGF","volume":"103","author":"Zhao","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.xcrm.2025.102371_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.115053","article-title":"Activation of PAR1 contributes to ferroptosis of Schwann cells and inhibits regeneration of myelin sheath after sciatic nerve crush injury in rats via Hippo-YAP\/ACSL4 pathway","volume":"384","author":"Wu","year":"2025","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.xcrm.2025.102371_bib37","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41580-023-00649-0","article-title":"FOXO transcription factors as mediators of stress adaptation","volume":"25","author":"Rodriguez-Colman","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2025.102371_bib38","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s13046-018-0980-3","article-title":"IMPDH2 promotes colorectal cancer progression through activation of the PI3K\/AKT\/mTOR and PI3K\/AKT\/FOXO1 signaling pathways","volume":"37","author":"Duan","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102371_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110564","article-title":"1,25D\/VDR inhibits pancreatic beta cell ferroptosis by downregulating FOXO1 expression in diabetes mellitus","volume":"105","author":"Ding","year":"2023","journal-title":"Cell. Signal."},{"key":"10.1016\/j.xcrm.2025.102371_bib40","first-page":"20","article-title":"FOXO1 reshapes neutrophils to aggravate acute brain damage and promote late depression after traumatic brain injury","volume":"11","author":"Zhou","year":"2024","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.xcrm.2025.102371_bib41","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/tox.24429","article-title":"Mevastatin-Induced HO-1 Expression in Cardiac Fibroblasts: A Strategy to Combat Cardiovascular Inflammation and Fibrosis","volume":"40","author":"Lee","year":"2025","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.xcrm.2025.102371_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101160","article-title":"Targeting NQO1 induces ferroptosis and triggers anti-tumor immunity in immunotherapy-resistant KEAP1-deficient cancers","volume":"77","author":"Yuan","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.xcrm.2025.102371_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adk0330","article-title":"TRPML1 triggers ferroptosis defense and is a potential therapeutic target in AKT-hyperactivated cancer","volume":"16","author":"Zhang","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2025.102371_bib44","article-title":"Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.xcrm.2025.102371_bib45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2015.08.068","article-title":"Preclinical mouse cancer models: a maze of opportunities and challenges","volume":"163","author":"Day","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102371_bib46","doi-asserted-by":"crossref","first-page":"21268","DOI":"10.1021\/acsnano.4c05084","article-title":"Biomineralization-Tuned Nanounits Reprogram the Signal Transducer and Activator of Transcription 3 Signaling for Ferroptosis-Immunotherapy in Cancer Stem Cells","volume":"18","author":"Zhao","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.xcrm.2025.102371_bib47","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1056\/NEJMoa1200933","article-title":"Vorapaxar in the secondary prevention of atherothrombotic events","volume":"366","author":"Morrow","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102371_bib48","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1038\/s41467-021-22772-2","article-title":"Loss of Ambra1 promotes melanoma growth and invasion","volume":"12","author":"Di Leo","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102371_bib49","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4161\/onci.20226","article-title":"Selective BRAF inhibition decreases tumor-resident lymphocyte frequencies in a mouse model of human melanoma","volume":"1","author":"Hooijkaas","year":"2012","journal-title":"OncoImmunology"},{"key":"10.1016\/j.xcrm.2025.102371_bib50","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1158\/1078-0432.CCR-17-3509","article-title":"A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell Populations","volume":"24","author":"Tamborero","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102371_bib51","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102371_bib52","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-gamma-related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J. Clin. Investig."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125004446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125004446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:14:22Z","timestamp":1788563662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125004446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2666379125004446"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102371","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vorapaxar enhanced mitochondria-associated ferroptosis primes cancer immunotherapy via targeting FOXO1\/HMOX1 axis","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102371","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102371"}}